SEC Filing Summary: Second Sight Medical Products, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on July 25, 2019, by Second Sight Medical Products, Inc. (Note: The request metadata referenced "Vivani Medical, Inc.", but the filing text explicitly identifies the registrant as Second Sight Medical Products, Inc.). The report addresses a notice from The Nasdaq Stock Market LLC regarding the Company's failure to meet the minimum bid price requirement for continued listing.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status regarding stock listing standards.
Material Changes and Events
- Delisting Notice: On January 25, 2019, the Company received notice that its common stock failed to meet the minimum $1.00 bid price requirement for 30 consecutive business days.
- Initial Compliance Period: Nasdaq granted an initial 180-day period (until July 24, 2019) to regain compliance, which the Company failed to achieve.
- Extension Granted: On July 25, 2019, Nasdaq granted an additional 180-day compliance period extending until January 20, 2020.
- Conditions for Extension: The extension was granted because the Company met all other initial listing standards, including the market value of publicly held shares, and provided written notice of intent to cure the deficiency, potentially via a reverse stock split.
Outlook, Risks, and Management Commentary
Management has indicated an intent to cure the deficiency, potentially by effecting a reverse stock split. To regain compliance, the closing bid price must be at least $1.00 per share for a minimum of 10 consecutive business days during the new period. The Company explicitly states it can give no assurance that it will regain compliance by January 20, 2020. If compliance is not demonstrated by that date, Nasdaq will notify the Company of delisting, at which point the Company may appeal to a hearings panel.
Investor Verification Checklist
- Verify the current trading price of Second Sight Medical Products, Inc. (Ticker: EYES) to assess proximity to the $1.00 threshold.
- Monitor for announcements regarding a potential reverse stock split to address the bid price deficiency.
- Confirm the Company's status regarding the market value of publicly held shares, which was a factor in granting the extension.
- Track the deadline of January 20, 2020, for the final determination on continued listing.